Quarterly report pursuant to Section 13 or 15(d)

Share-Based Compensation (Tables)

v3.19.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2019
Schedule of Assumptions Used to Determine Grant Date Fair Value of Employee and Director Options Granted

Error extracting Word content

Summary of Restricted Ordinary Shares Activity

The following table summarizes restricted ordinary shares activity for the three months ended March 31, 2019:

 

 

 

Number of Shares

 

 

Weighted

Average Grant Date Fair Value per Share

 

Unvested at December 31, 2018

 

 

86,068

 

 

$

3.14

 

Granted

 

 

 

 

 

 

 

Vested

 

 

(25,818

)

 

$

3.14

 

Forfeited

 

 

 

 

 

 

 

Unvested at March 31, 2019 (unaudited)

 

 

60,250

 

 

$

3.14

 

Summary of Number of Options Outstanding and Weighted-average Exercise Price

The following table summarizes the number of options outstanding and the weighted-average exercise price:

 

 

 

Number of

Shares

 

 

Weighted

Average Exercise

Price

 

 

Weighted

Average

Remaining

Contractual Life

in Years

 

 

Aggregate

Intrinsic

Value

(in thousands)

 

Options outstanding December 31, 2018

 

 

665,219

 

 

$

9.31

 

 

 

8.93

 

 

395

 

Granted

 

 

442,500

 

 

 

5.82

 

 

 

 

 

 

 

 

 

Exercised

 

 

(15,395

)

 

 

3.16

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(1,086

)

 

 

9.44

 

 

 

 

 

 

 

 

 

Options outstanding March 31, 2019

 

 

1,091,238

 

 

$

7.98

 

 

 

9.27

 

 

 

1,956

 

Exercisable at March 31, 2019 (unaudited)

 

 

106,325

 

 

$

4.59

 

 

 

8.25

 

 

 

425

 

Summary of Number of RSUs Granted and Weighted-average Grant Date Fair Value of RSUs

The table below shows the number of RSUs granted covering an equal number of our ordinary shares and the weighted-average grant date fair value of the RSUs granted:

 

 

 

Number of

Shares

 

 

Weighted Average

Grant Date Fair

Value per Share

 

RSUs outstanding December 31, 2018

 

 

36,924

 

 

$

13.00

 

Granted

 

 

 

 

 

 

 

Shares vested

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

RSUs outstanding March 31, 2019

 

 

36,924

 

 

$

13.00

 

Summary of Share-based Compensation Expense

The Company’s share-based compensation expense was classified in the condensed consolidated statements of operations and comprehensive loss as follows:

 

 

 

Three Months Ended March 31,

 

 

 

2019

 

 

2018

 

Research and development expense

 

$

163

 

 

$

71

 

General and administrative expense

 

 

377

 

 

 

78

 

Performance RSU [Member}  
Summary of Number of RSUs Granted and Weighted-average Grant Date Fair Value of RSUs

The table below shows the number of Performance RSUs granted covering an equal number of our ordinary shares and the weighted-average grant date fair value of the Performance RSUs granted:

 

 

Number of

Shares

 

 

Weighted Average

Grant Date Fair

Value per Share

 

Performance RSUs outstanding December 31, 2018

 

 

 

 

 

 

 

Granted

 

 

50,000

 

 

$

8.21

 

Shares vested

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

Performance RSUs outstanding March 31, 2019

 

 

50,000

 

 

$

8.21